Olney, MD, United States of America

Ulrich F Tillmann


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ulrich F Tillmann

Introduction

Ulrich F Tillmann is a notable inventor based in Olney, MD, USA, recognized for his significant contributions to the field of biotechnology. With a portfolio boasting two patents, Tillmann has focused his research on developing innovative solutions for medical applications, particularly in immunology.

Latest Patents

Among his latest inventions is a groundbreaking patent that discloses the outer membrane protein polypeptide known as OMP21, along with its nucleotide sequences and the antibodies that specifically bind to it. This invention presents pharmaceutical compositions that include prophylactic or therapeutic applications, which may consist of immunogenic compositions such as vaccines incorporating OMP21, antibodies, or nucleotides encoding the polypeptide. Furthermore, this patent outlines methods to induce an immune response against OMP21 in humans, alongside methodologies for diagnosing and treating infections caused by Moraxella catarrhalis, thereby enhancing therapeutic strategies in infectious disease management.

Career Highlights

Throughout his career, Tillmann has been associated with several esteemed companies in the biotechnology sector, including Antex Biologics, Inc. and Emergent Product Development in Gaithersburg, Maryland. His work at these companies has played a vital role in advancing immunological research and product development.

Collaborations

Ulrich F Tillmann has worked alongside notable professionals in his field, including his coworker Kenneth D Tucker. This collaboration has contributed to enriching the research landscape, fostering advancements in their shared areas of expertise.

Conclusion

Ulrich F Tillmann exemplifies the spirit of innovation and dedication within the biotechnology sector. His research and patents reflect a commitment to improving healthcare outcomes through scientific advancements. As he continues to explore new frontiers in biomedicine, Tillmann's work remains essential to the evolution of therapeutic solutions aimed at combating infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…